Summary | Swiss drugmaker Novartis AG is considering a possible
initial public offering (IPO) in China, joining a growing list
of multinationals interested in selling yuan-denominated shares
in Shanghai, two people with knowledge of the situation said.
chinadaily.com.cn | 16 April 2015